Hansa Biopharma to host conference call to provide interim results for January-March 2023 and a Business Update

/PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-March 2023 at 8:00 CET on April 20, 2023. All...

Related Keywords

Sweden ,Copenhagen ,Køavn ,Denmark ,Boston ,Massachusetts ,United States ,United Kingdom ,Canada ,Stockholm ,Tulstrup ,Hovedstaden ,Amsterdam ,Noord Holland ,Netherlands ,Gothenburg ,Vastra Gotalands Lan ,Hansa Biopharma ,Donato Spota ,Stephanie Kenney ,Klaus Sindahl ,Erik Penser Company Day ,Vp Global Corporate Affairs ,Van Lanschot Kempen Life Sciences Conference ,Redeye Investor Forum ,Nasdaq Stockholm ,Interim Report ,Midcap Canada ,Penser Company Day ,Redeye Investor ,Annual General ,Half Year Report ,Biopharma Conference ,Morganstanley Global Healthcare Conference ,Pareto Annual Healthcare Conference ,Ugebrev Life Science Event ,Hansa Biopharma Ab ,